FAVERO, GAIA
 Distribuzione geografica
Continente #
NA - Nord America 5.145
EU - Europa 2.491
AS - Asia 1.226
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
SA - Sud America 6
AF - Africa 1
Totale 8.883
Nazione #
US - Stati Uniti d'America 5.135
CN - Cina 750
UA - Ucraina 731
PL - Polonia 597
DE - Germania 309
IT - Italia 252
HK - Hong Kong 226
FI - Finlandia 172
FR - Francia 124
IE - Irlanda 123
SG - Singapore 117
GB - Regno Unito 95
IN - India 75
VN - Vietnam 29
BE - Belgio 23
CZ - Repubblica Ceca 17
SE - Svezia 17
RU - Federazione Russa 15
TR - Turchia 13
CA - Canada 8
EU - Europa 7
AU - Australia 6
ES - Italia 5
NL - Olanda 5
JP - Giappone 4
BR - Brasile 2
KR - Corea 2
SA - Arabia Saudita 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
TH - Thailandia 1
Totale 8.883
Città #
Fairfield 756
Warsaw 596
Woodbridge 540
Jacksonville 524
Houston 412
Ann Arbor 409
Ashburn 356
Seattle 334
Cambridge 290
Wilmington 290
Chandler 245
Princeton 224
Hong Kong 222
Nanjing 162
Beijing 148
Dublin 119
New York 110
Brescia 95
Helsinki 80
Dearborn 74
Singapore 69
Des Moines 57
Nanchang 49
Hebei 48
San Diego 45
Shenyang 43
Changsha 42
Milan 40
Jiaxing 37
Boardman 32
Jinan 32
Shanghai 32
Dong Ket 28
Tianjin 26
Brussels 23
Hangzhou 23
Kunming 15
Grafing 14
San Francisco 14
Brno 13
Lappeenranta 13
Haikou 12
Ningbo 12
London 11
Orange 10
Lanzhou 9
Norwalk 9
Los Angeles 8
Zhengzhou 8
Pune 7
Verona 7
Lancaster 6
Phoenix 6
Taizhou 6
Bergamo 5
Changchun 5
Fuzhou 5
Guangzhou 5
Kocaeli 5
Munich 5
Taiyuan 5
Toronto 5
Cosenza 4
Hefei 4
Melbourne 4
Tokyo 4
Acton 3
Hanover 3
Kilburn 3
Leawood 3
Olomouc 3
Prescot 3
Redwood City 3
Rome 3
San Mateo 3
Torino 3
Walnut 3
Andover 2
Brindisi 2
Buguggiate 2
Central 2
Chengdu 2
Chiswick 2
Dalmine 2
Drogheda 2
Ferrara 2
Hospitalet De Llobregat 2
Hounslow 2
Madrid 2
Markham 2
Napoli 2
Nürnberg 2
Philadelphia 2
Riyadh 2
Sesto San Giovanni 2
Strasbourg 2
Sundsvall 2
Albignasego 1
Alexandria 1
Amsterdam 1
Totale 6.924
Nome #
Role of heme oxygenase in modulating endothelial function in mesenteric small resistance arteries of spontaneously hypertensive rats. 248
Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease 219
NF-kB- A key factor in atherogenesis and atheroprogression. 206
Taurine supplementation alleviates puromycin aminonucleoside damage by modulating endoplasmic reticulum stress and mitochondrial-related apoptosis in rat kidney 197
Perspective: Mitochondria-ER Contacts in Metabolic Cellular Stress Assessed by Microscopy 169
Resveratrol and Sirt 1 activators for the treatment of aging and age-related diseases 155
Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. 141
Anticontractile activity of perivascular fat in obese mice and the effect of long-term treatment with melatonin. 136
Sirtuins, aging, and cardiovascular risks 136
AQP1 expression in human gingiva and its correlation with periodontal and peri-implant tissue alterations. 126
Aging and vascular dysfunction: beneficial melatonin effects 123
Impact of melatonin on skeletal muscle and exercise 121
Effect of long-term treatment with melatonin on vascular markers of oxidative stress/inflammation and on the anticontractile activity of perivascular fat in aging mice 120
A comparative pilot study of two dental implant metals in a pig model 117
Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats. 114
Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation 111
Acute mercury exposition of virgin, pregnant, and lactating rats: Histopathological kidney and liver evaluations 110
Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model 109
Sodium-DNA for Bone Tissue Regeneration: An Experimental Study in Rat Calvaria 109
Synapsin III alterations in Parkinson's disease 108
Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases 108
Sirtuin 6 nuclear localization at cortical brain level of young diabetic mice: An immunohistochemical study 107
Melatonin reduces obesity and restores adipokine patterns and metabolism in obese (ob/ob) mice 107
Nicotine-Induced Morphological Changes in Rat Aorta: The Protective Role of Melatonin 103
Aging and vascular dysfunction: beneficial melatonin effects. 103
Melatonin and its atheroprotective effects: A review. 103
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 103
Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet 98
Melatonin sirtuin1-dependent mechanism of action in an hypercholesterolemic animal model 97
Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fraction 94
Melatonin: Protection against age-related cardiac pathology 94
Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis 94
Changes in extracellular matrix in subcutaneous small resistance arteries of patients with essential hypertension 93
Obesity-related dysfunction of the aorta and prevention by melatonin treatment in ob/ob mice 91
Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients 91
Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy. 90
Attenuation of ultraviolet A-induced alterations in NIH3T3 dermal fibroblasts by melatonin. 89
Mitochondrial and metabolic dysfunction in renal convoluted tubules of obese mice: protective role of melatonin 89
Oral supplementation of melatonin protects against fibromyalgia-related skeletal muscle alterations in reserpine-induced myalgia rats 88
Melatonin reduces excitotoxic blood-brain barrier breakdown in neonatal rats 87
Atherosclerosis and Current Anti-Oxidant Strategies for Atheroprotection 87
Thymus and aging: morphological, radiological, and functional overview. 85
Endothelial and vascular smooth muscle cell dysfunction mediated by cyclophylin A and the atheroprotective effects of melatonin 83
Upregulation of HO-1 accompanied by an increase in adiponectin improves cardiac function via Pamp-Penos pathway in spontaneously hypertensive rats. 81
Fibronectin but not laminin content is increased in the tunica media of subcutaneous small resistance arteries of patients with essential hypertension 79
Melatonin Modulation of Sirtuin-1 Attenuates Liver Injury in a Hypercholesterolemic Mouse Model 79
Endoplasmic reticulum stress in the endothelium: a contribution to atherosusceptibility 77
Mitochondrial dysfunction in skeletal muscle of a fibromyalgia model: The potential benefits of melatonin 76
Beneficial effects of melatonin on nicotine-induced vasculopathy 75
Collagen subtypes in the tunica adventitia of subcutaneous small resistance arteries of patients with primary aldosteronism. 75
EET agonist improves cardiac energy metabolism and heart function by regulating fatty acid oxidation and oxidative stress in infarcted myocardium. 75
Vascular oxidative stress-induced senescence is minimized by melatonin intake in Apo-E deficient mice 74
Does melatonin protect dermis fibroblasts from UVA radiations? 74
Browning of Adipose Tissue and Sirtuin1 Involvement. 74
Endothelium and its alterations in cardiovascular diseases: life style intervention. 73
Vascular aging and melatonin beneficial effects 73
Melatonin in plant-based food: implications for human health. 73
Vascular aging and melatonin beneficial effects 72
Melatonin efficacy in obese leptin-deficient mice heart 72
Promising antineoplastic actions of melatonin 72
Synapsin III Alteration in Parkinson's disease 71
Atheroslerosis and current anti-oxidant strategies for atheroprotection 70
Synapsin III Alteration in Parkinson's disease 70
Anti-atherosclerotic properties of wild rice in low-density lipoprotein receptor knockout mice: The gut microbiome, cytokines, and metabolomics study 70
Melatonin impact on cyclosporine-induced liver damage: an update 69
Endothelial and neural cell marker alterations in dorsal root ganglia during inflammatory pain. 67
Sirtuin 6 localization at cortical brain level of young diabetic mice. 67
Development of NASH in Obese Mice is Confounded by Adipose Tissue Increase in Inflammatory NOV and Oxidative Stress 67
Vascular cell dysfunctions: a possible atheroprotective role of melatonin 66
Melatonin limited early atherosclerotic changes in ApoE null mice 65
Effect of long-term treatment with melatoni against obesity related dysfunctions in obese mice. 65
Metabolic sindrome and melatonin: a tool for prevent obesity-associated abnormalities. 64
A carnosine analog with therapeutic potentials in the treatment of disorders related to oxidative stress 64
CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype. 63
Vascular endothelial cells and dysfunctions: role of melatonin 62
Melatonin reduces ER stress and steatosis in liver of obese mice: a microscopic appraisal 62
Antitumor activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signaling. 62
Role of Apolipoprotein E in liver aging protection 61
Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain 60
Changes of collagen subtypes in the tunica adventitia of subcutaneous small resistance arteries of patients with primary aldosteronism 60
Melatonin promotes beneficial Mitofusin 2 in obese mice kidney. 59
A comparison of melatonin and α-lipoic acid in the induction of antioxidant defences in L6 rat skeletal muscle cells 59
Effect of long-term treatment with melatonin against obesity related dysfunctions in obese mice. 59
Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1α-HO-1-PGC1α-mitochondrial signaling 59
Biomaterials in maxillofacial surgery: membranes and grafts 57
Site-specific heme oxygenase-1 expresion into adipocytes leads to increase in EET levels reduced adiposity and blood pressure in obese mice. 56
Heme oxygenase-1 mediated PPARδ improves cardiac fibrosis and inflammation in SCID mice via induction of T Reg cells. 54
Modificazioni dei sottotipi di collagene nell’avventizia di arterie di resistenza sottocutanee in pazienti affetti da iperaldosteronismo primitivo. 54
CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high fat diet by reprogramming adipocyte phenotype. 53
Metabolic syndrome and beneficial vascular effect of melatonin. 52
Protective role of melatonin against obesity-associated vascular dysfunctions. 51
Anti-atherogenic diets: observations from mouse models. 51
Fibronectin and laminin content in the tunica media of subcutaneous small resistance arteries of patients with essential hypertension. 50
HO-1 involvement in iron homeostasis in liver of obese mice. 50
Enhanced VEGF and ETS-1 recruitment by T reg heme oxygenase-1 module increases blood flow in post-infarction myocardium in SCID mice. 50
Contenuto di fibronectina e laminina nella tonaca media delle piccole arterie di resistenza sottocutanee in pazienti con ipertensione essenziale. 48
Melatonin and obesity-associated cardiovascular alterations 47
Melatonine reduces BBB breakdown in a rat model of neonatal excitotoxic damage. 47
Leptin-deficient obese mice: a multi-organ stress model rescued by melatonin 47
STRESS PROTEINS IN EXPERIMENTAL NEPHROTOXICITY: A TEN YEAR EXPERIENCE 46
Totale 8.687
Categoria #
all - tutte 41.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.298 0 90 104 268 162 289 258 320 216 327 119 145
2020/20211.745 41 177 41 241 66 197 54 215 198 259 173 83
2021/2022936 67 131 16 81 12 46 44 62 38 128 94 217
2022/2023761 136 20 13 53 87 200 3 79 99 3 29 39
2023/2024833 55 24 63 54 39 135 24 35 234 21 12 137
2024/202537 22 15 0 0 0 0 0 0 0 0 0 0
Totale 9.154